Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
Aclaris Therapeutics(ACRS) Newsfilter·2024-07-17 04:01Aclaris Therapeutics(ACRS) Newsfilter·2024-07-17 04:01
R1Aclaris Therapeutics(ACRS) Newsfilter·2024-07-17 04:01